Leading Exporters and Wholesaler of Rexigo 120mg Relugolix Tablet, Ribaxa 150mg Olaparib Tablet, Rituxirel 100mg Rituximab Injection, Rituxirel 500mg Rituximab Injection, Rituxirel RN 500mg Rituximab Injection, Rozel 60mg Denosumab Injection, Sigrima 420mg Pertuzumab Injection, Somalinx 30mg Octreotide Injection, Sorafekast 200mg Sorafenib Tablet, Spegra Dolutegravir Emtricitabine Tenofovir Alafenamide Tablet, Sutinat Sunitinib Malate Capsule, Tamtero 20mg Tamoxifen Citrate Tablet, Temoside 100mg Temozolomide Capsule, Temoside 250mg Temozolomide Capsule, Thalix 50mg Thalidomide Capsule, Tipanat 20mg Trifluridine Tipiracil Tablet, Tuccatinn 150mg Tucatinib Tablet, Ujvira 100mg Trastuzumab Emtansine Injection, Vectibix 100mg Panitumumab Injection, Veenat 400mg Imatinib Tablet, Versavo 400mg Bevacizumab Injection and Xbira 500mg Abiraterone Acetate Tablet from Delhi.
| Business Type | Exporter, Supplier |
| Manufacturer | ZYDUS |
| Brand Name | Rexigo |
| Packaging Type | Bottle |
| Form | Tablet |
| Packaging Size | 10 Tablet(s) In A Strip |
| Salt Composition | Relugolix |
Rexigo 120mg Tablet contains Relugolix, a medicine used to treat adult men with advanced hormone-sensitive prostate cancer. It belongs to a group of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists, which work by reducing the levels of testosterone, a hormone that fuels the growth of prostate cancer cells.
By lowering testosterone production, Rexigo 120mg helps slow down or stop the spread of prostate cancer. This can also reduce symptoms such as difficulty in urination or pain associated with the disease. The treatment is taken orally and offers an alternative to injections or surgical options used for testosterone suppression.
| Business Type | Exporter, Supplier, Trader |
| Strength | 150 Mg |
| Brand Name | Ribaxa |
| Usage | Breast Cancer, Pancreatic Cancer, Ovarian Cancer |
| Packaging Type | Bottle |
| Salt Composition | Olaparib Tablets |
| Marketer | DR REDDY'S |
Ribaxa+ 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
It is not recommended to take olaparib if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
It is not advised to use this medication while pregnant since it may harm the fetus and cause miscarriage. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because it is unknown if Ribaxa+ 100mg tablet will find its way into the breast milk. Men are not advised to donate sperm for at least 3 months after the treatment is finished. It is necessary to inform your doctor about all the medicines you are taking including prescription, over the counter drugs, vitamins and supplements. Ribaxa+ 150mg substitutes for Ribaxa+ 150mg Tablet in India is Olparib 150mg Tablet. Ribaxa+ 150mg Tablet price varies by retailer and location. You can Buy Ribaxa+ 150mg Tablet online no various platforms like MrMed at Affordable Prices.
| Business Type | Exporter, Supplier |
| Brand Name | Rituxirel |
| Shelf Life | 24 Months |
| Strength | 100 Mg |
| Packaging Type | Vial |
| Packaging Size | 10 Ml |
| Manufacturer | Reliance Life Sciences Pvt Ltd |
| Storage Temperature | 2-8 Degree C |
| Salt Composition | Rituximab |
Rituxirel 100mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the leukapheresis body cells of its own joints) in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals.
Rituxirel 100mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.
Common side effects of Rituxirel 100mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.
| Business Type | Exporter, Supplier |
| Brand Name | Rituxirel |
| Shelf Life | 24 Months |
| Strength | 500 Mg |
| Packaging Type | Vial |
| Packaging Size | 50 Ml |
| Manufacturer | Reliance Life Sciences Pvt Ltd |
| Storage Temperature | 2-8 Degree C |
| Salt Composition | Rituximab 500mg Injection |
Rituxirel 500mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the leukapheresis body cells of its own joints) in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals.
Rituxirel 500mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.
Common side effects of Rituxirel 500mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.
| Business Type | Exporter, Supplier |
| Manufacturer | Reliance Life Sciences |
| Shelf Life | 36 Months |
| Packaging | Vial |
| Treatment | Non-Hodgkin Lymphoma |
| Composition | Rituximab |
| Strength | 500 Mg |
| Brand | Rituxirel |
| Storage Temperature | 2-8 Degree C |
Rituxirel RN 500mg Injection contains rituximab, a type of medicine known as an anti-CD20 monoclonal antibody. It is used in adults to treat various types of blood cancers like non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL). It also helps manage autoimmune diseases such as rheumatoid arthritis (RA), when used with methotrexate, as well as granulomatosis with polyangiitis and microscopic polyangiitis (inflammatory conditions affecting blood vessels). Additionally, it is prescribed for pemphigus vulgaris, a rare condition that causes painful skin blisters and sores in the mouth, throat, and other areas.
This injection works by targeting specific white blood cells called B-lymphocytes, which may grow abnormally in cancer or behave incorrectly in autoimmune conditions. Rituxirel RN 500mg is given under the supervision of a qualified healthcare professional. It’s not recommended if you are allergic to rituximab, have severe infections, or have a weakened immune system.
Before starting treatment, tell your doctor if you have heart or lung problems, or a history of hepatitis B infection, as the virus can reactivate during treatment. Pregnant and breastfeeding women should avoid this injection. Effective contraception is advised during treatment and for at least 12 months after the last dose.
Common side effects may include low red blood cells, infections, itchy skin, swelling, diarrhea, or changes in blood pressure. Serious side effects like infusion-related reactions, chest pain, or difficulty breathing should be reported to your doctor immediately.
| Business Type | Exporter, Supplier |
| Brand Name | Rozel |
| Application | Treatment Of Osteoporosis |
| Packaging Type | Vial |
| Dosage | 60mg |
| Active Ingredient | Denosumab |
| Manufacturer | Intas |
| Storage | Store In A Cool, Dry Place |
| Expiry | 2 Years |
Rozel 60mg Injection contains the active ingredient denosumab and is used rozel for osteoporosis and to prevent bone complications in patients with cancer. Rozel injection uses include treating osteoporosis (to strengthen weakened bones) and managing bone loss related to cancers such as rozel injection for multiple myeloma and rozel injection for bone cancer (bone metastases). Rozel 60mg price varies by city, hospital and supplier, so check local pharmacies or your hospital for current rates.
Rozel works by inhibiting RANK ligand, a protein involved in bone breakdown, and studies have shown it can increase bone density and reduce fracture risk in postmenopausal women and patients with cancer-related bone loss. The exact rozel injection dosage and how to take rozel injection are determined by your oncologist or specialist (it is administered in a clinic and requires monitoring). In discussions of rozel vs prolia, both are denosumab-based products—differences are mostly brand, approved indications and cost—so talk to your doctor or pharmacist about which option is right for you.
| Business Type | Exporter, Supplier |
| Packaging | Vial |
| Manufacturer | Zydus Lifescience Ltd. |
| Strength | 420 Mg |
| Brand | Sigrima |
| Salt Composition | Pertuzumab |
| Packing Size | 1 Vial(s) Of 14ml |
Sigrima 420mg Injection, is a targeted therapy containing the active constituents pertuzumab and trasrtuzumab. It is used to treat a type of breast cancer (human epidermal growth factor receptor 2 positive breast cancer) that has spread to other parts of the body (metastasized) or cancer that has come back after the treatment. It will also be given before or after the surgery if the cancer has not metastasized. Cancer occurs when cells begin to grow abnormally in an uncontrolled manner.
Before taking Sigrima 420mg Injection, talk to the physician if you have heart problems, have had radiotherapy, or have allergic conditions. This medication is not recommended for adolescents and children under 18. In patients with early-stage HER2-positive breast cancer, adding pertuzumab or trastuzumab to standard chemotherapy can reduce the risk of recurrence and improve disease-free survival.
| Business Type | Exporter, Supplier |
| Packaging Type | Box |
| Brand | Somalinx |
| Strength | 30 Mg |
| Pack Size | 1 Ml |
| Storage | Below 25°C |
| Usage | Acromegaly |
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Shelf Life | 36 Months |
| Salt Composition | Octreotide 30mg Injection |
Somalinx 30mg injection contains the active substance octreotide. It is a synthetic compound derived from somatostatin, a substance naturally found in the human body that inhibits the effects of certain hormones, such as growth hormones. It is used to reduce the amount of growth hormone produced by people with acromegaly (a condition in which the body produces too much growth hormone, causing enlargement of the hands, feet, and facial features; joint pain; and other symptoms) who cannot be treated with surgery, radiation, or another medication.
It is also used to control diarrhea and flushing caused by carcinoid tumors (slow-growing tumors that release natural substances that can cause symptoms) and vasoactive intestinal peptide-secreting adenomas (VIP-omas; tumors that form in the pancreas and release natural substances that can cause symptoms). It is used to prevent complications following surgery of the pancreas gland. It is also indicated to stop bleeding and to protect from re-bleeding from ruptured gastro-esophageal varices in patients suffering from chronic liver disease. This medicine is used to treat people with pituitary tumors that produce too much thyroid-stimulating hormone (TSH) when other types of treatment (surgery or radiotherapy) are not suitable or have not worked and after radiotherapy, to cover the interim period until the radiotherapy becomes fully effective.
Do not use this medicine if you are allergic to octreotide or any of the other ingredients of this medicine. Inform your physician if you have gallstones, high or low blood sugar levels, vitamin B12 deficiency, and liver diseases. Somalinx 30mg injection may lower your heart rate, and very high doses can cause abnormal heart rhythm, so your doctor may monitor your heart function regularly during the treatment. Inform your physician if you are pregnant or breastfeeding before initiating the treatment.
| Business Type | Exporter, Supplier |
| Strength | 200 Mg |
| Brand Name | Sorafekast |
| Composition | Sorafenib |
| Packaging Type | Box |
| Packaging Size | 120 Tablets |
| Form | Tablet |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
Sorafekast Tablet belongs to the group of medicines called anti-cancer. It consists of the active ingredient Sorafenib which is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients ineligible for surgery, and differentiated thyroid carcinoma (thyroid cancer) in patients who are not responsive to radioactive iodine therapy.
Diarrhea, tiredness, stomach pain, nausea, weakness, rashes, flu-like illness, appetite loss, nausea, weight loss, and low blood calcium levels are common side effects of Sorafekast Tablet. Inform your doctor if any of these side effects disturb or persist with you.
Inform your doctor if you are allergic to this Tablet and its ingredients. Before starting treatment with this tablet, you should tell your physician if you have heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. Use effective contraception during the therapy and for 6 months after the last dose if you are a woman or 3 months after the last dose if you are a man.
| Business Type | Exporter, Supplier |
| Brand Name | Spegra |
| Composition | Dolutegravir, Emtricitabine And Tenofovir Alafenamide Tablets |
| Form | Tablet |
| Strength | 50/200/25mg |
| Packaging Size | 30 Tablets |
| Packaging Type | Bottle |
| Drug Class | NRTI |
Spegra Tablet contains the active ingredients Dolutegravir, Emtricitabine, and Tenofovir Alafenamide. It is a combination of antiretroviral medication. Dolutegravir belongs to a class of antiretroviral drugs called integrase strand transfer inhibitors (INSTIs). Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is combined with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age who weigh at least 35kg.
The combination is available as a single tablet regimen, simplifying treatment by reducing the number of pills a person must take daily. This convenience improves medication adherence, ensuring individuals can consistently take their prescribed medication as scheduled. Do not take Spegra Tablet if anyone is allergic to it or its components. Get tested for HIV infection regularly while using this medicine. Missing a dose increases the risk of getting HIV infection. This medicine does not prevent other sexually transmitted infections (STIs). Patients should inform the physician if they have liver problems or liver disease, including hepatitis, kidney, and bone problems. This HIV medication is not recommended to give in to children aged 11 years or under.
| Business Type | Exporter, Supplier |
| Brand | Sutinat |
| Strength | 25 Mg |
| Packaging Size | 28 Capsules |
| Indication | GIST, PNET, RCC |
| Salt Composition | Sunitinib Malate |
| Manufacturer | Natco Pharma Ltd |
Sutinat 25mg Capsule consists of the active ingredient Sunitinib. It is classified as a tyrosine kinase inhibitor, which means that it works by blocking certain enzymes called tyrosine kinases that are involved in the growth and spread of cancer cells. This medication treats gastrointestinal stromal tumors (GIST), a rare cancer that can start anywhere in the gastrointestinal tract. This medication is also used to treat advanced kidney cancer and pancreatic cancer called pancreatic neuroendocrine tumors (PNET). Cancer is a disorder in which abnormal cells grow in an uncontrolled manner. It is not recommended for people under 18.
Before taking Sutinat 25mg Capsule, it is important to discuss with the physician if you have blood conditions, heart problems, liver disorders, kidney problems, skin disorders, diabetes, seizures, or thyroid disorders. Also, inform if you have recently had or are about to have surgery. Tell your doctor if you are hypertensive because this medication sometimes causes hypertension as a side effect. Avoid taking grapefruit in any form during the treatment with Sutinat 25mg Capsule. Check with your dentist if you have any problems in the mouth, such as mouth pain, swelling, or sores inside the mouth, before starting treatment.
| Business Type | Exporter, Supplier |
| Brand Name | Tamtero |
| Application | Breast Cancer |
| Packaging Type | Box |
| Strength | 20 Mg |
| Tablets Per Pack | 100 Tablets |
| Salt Composition | Tamoxifen Citrate Tablets |
| Manufacturer | HETERO HEALTHCARE LTD |
Tamtero 20mg Tablet contains Tamoxifen citrate. It is used to treat and prevent breast cancer. It is also used to treat infertility in women caused by a failure to produce and release eggs properly. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.
Tamtero 20mg Tablet should not be used if you are pregnant, taking treatment for infertility, taking medicines to treat blood clots, and if you have had or having blood clots with the cause not known. Talk to your doctor if you have uterine cancer or other problems with your uterus, irregular periods, abnormal vaginal bleeding, or had a stroke before taking this medicine. Use effective birth control during the treatment and for at least 9 months after the last dose.
| Business Type | Exporter, Supplier |
| Packaging Type | Bottle |
| Form | Capsule |
| Strength | 100 Mg |
| Brand Name | Temoside |
| Capsules Per Pack | 5 Capsules |
| Usage | Brain Tumor |
| Prescription Type | Prescription |
| Salt Composition | Temozolomide Capsules |
| Marketer | CIPLA LTD |
Temoside 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temoside 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temoside 100mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to associate with Temoside 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temoside 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
| Business Type | Exporter, Supplier |
| Strength | 250 Mg |
| Brand Name | Temoside |
| Packaging Type | Bottle |
| Form | Capsule |
| Capsules Per Pack | 5 Capsules |
| Usage | Brain Tumor |
| Salt Composition | Temozolomide Capsules |
Temoside 250mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antineoplastic agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Temoside 250mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Temoside 250mg Capsule, and it is continued as maintenance therapy.
The common side effects that are likely to be associated with Temoside 250mg Capsule are nausea, vomiting, dizziness, diarrhoea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.
Inform your physician if you are allergic to Temoside 250mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anaemia, low platelet count, low levels of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.
| Business Type | Exporter, Supplier |
| Form | Capsule |
| Packaging Size | 10 Capsules |
| Brand | Thalix |
| Strength | 50 Mg |
| Capsules Per Pack | 30 Capsules |
| Composition | Thalidomide |
| Manufacturer | Fresenius Kabi India Pvt Ltd |
| Packaging Type | Box |
Thalix 50mg Capsule belongs to the class of medications called immunomodulatory agents. It consists of the active ingredient Thalidomide, which works by inhibiting the growth of cancer cells and modulating the immune system. Thalix is also prescribed for conditions like erythema nodosum leprosum (a complication of leprosy) and other off-label uses, under strict medical supervision due to its potential side effects. As a powerful therapy, Thalix should only be taken as directed by a healthcare professional to ensure its safety and effectiveness.
The common side effects that are likely to be associated with Thalix 50mg Capsule are sleepiness, headache, dizziness, rashes, pain, tiredness, constipation, nausea, impotence, loss of appetite, fever, depression, etc. Inform your doctor if these side effects disturb or persist in you.
Inform your medical professional if you are allergic to Thalix 50mg Capsule and its ingredients. Inform your doctor if you have blood clots, heart attack, neuropathy (pain in the hands or feet caused by nerve damage), slow heart rate, low and high blood pressure, liver or kidney problems, viral infections like HIV, hepatitis B virus, and varicella zoster. Your physician will monitor the thyroid function before and during treatment with this medication. Stop taking Thalix 50mg Capsule and consult a doctor immediately if you have to think you are pregnant, if you have irregular periods, missed a period, have any change in menstrual bleeding, or if you had sex without using effective birth control. It is not recommended for adolescents and children under 18 years of age.
| Business Type | Exporter, Supplier |
| Manufacturer | Natco Pharma Ltd |
| Strength | 20 Mg/ 8.19 Mg |
| Brand | Tipanat |
| Packaging Size | 20 Tablets |
| Form | Tablet |
| Indication | Metastatic CRC |
| Packaging Type | Bottle |
| Salt Composition | Trifluridine And Tipiracil 20mg Tablets |
Tipanat 20mg tablet is an anticancer medication containing the two active constituents Trifluridine and Tipiracil. Tipanat 20 uses in treating adults with colon and rectum cancer when it reaches the metastases stage (cancer has spread to other parts of the body) and when other treatments are unsuitable. Trifluridine inhibits the growth of cancer cells, whereas Tipiracil stops the Trifluridine from being broken down and helps it to work longer. Cancer is a condition in which the cells multiply uncontrolled and abnormally. This medicine is not recommended for adolescents and children under 18.
Do not consume this medicine if you are allergic to Tipanat 20mg or other ingredients. Before starting the treatment, notify your doctor if you have a problem with your kidney or liver and are lactose intolerant. This treatment may lead to side effects such as neutropenia (lowered WBC), anemia (reduced number of RBC), and gastrointestinal problems. Report your doctor if you experience any side effects or symptoms. Dose adjustment is needed in patients with a kidney condition. Inform your doctor if you are preganat or planning to get pregnant; this medicine may harm the unborn baby, so use contraception by both males and females during and after the treatment for six months. Tipanat 20 price varies from retailer to retailer and Location.
| Business Type | Exporter, Supplier |
| Packaging | Bottle |
| Composition | Tucatinib |
| Strength | 150 Mg |
| Brand | Tuccatinn |
| Packaging Size | 60 Capsules |
| Form | Capsule |
| Marketer | BDR PHARMACEUTICALS INTERNATIONALS PVT LTD |
Tuccatinn 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
This medicine works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tuccatinn 150mg Tablet helps slow down or stop the cancer from spreading further.
It is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice and regular checkups are needed during treatment to make sure the medicine is working safely.
| Business Type | Supplier, Trader |
| Treatment | Gastric Cancer, Breast Cancer |
| Packaging | Single-Use Vial |
| Brand Name | Ujvira |
| Manufacturer | Zydus |
| Strength | 100 Mg |
| Drug Type | Trastuzumab Emtansine |
| Storage Temperature | 2-8 Degree C |
Ujvira 100mg Injection is a targeted therapy containing the active constituent trastuzumab emtansine. The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine on February 22, 2013, for treating patients with HER2-positive metastatic breast cancer who have previously received trastuzumab and chemotherapy. This medication is not recommended for adolescents and children under 18. Before taking this medicine, it is vital to inform your doctor if you have any blood clot disorders, liver disorders, or allergies.
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Ujvira 100mg Injection and cause undesirable side effects.
| Business Type | Exporter, Supplier |
| Storage | 2 To 8 Degree C |
| Composition | Panitumumab |
| Packaging | Box |
| Brand | Vectibix |
| Strength | 100 Mg |
| Packaging Size | 5ml (20mg/ml) |
Vectibix 100mg injection is an anticancer drug belonging to the class of epidermal growth factor receptor (EGFR) inhibitors, containing the active ingredient Panitumumab. It is used to treat metastatic colorectal cancer (cancer that begins in the colon or rectum and has spread to other parts of the body).
It is not recommended to take this injection if you are allergic to any of its ingredients. This drug targets certain proteins in the body, which can increase the risk of bleeding. If you experience any signs of bleeding while taking this drug, such as unusual bleeding or bruising, black or tarry stools, blood in the urine, or bleeding gums, you should contact your doctor immediately. Your doctor may need to adjust your dose or temporarily stop the treatment. Eye problems can occur while on the treatment with this medicine such as inflammation and damage to the cornea, and the symptoms may include eye pain, redness, blurred vision, and sensitivity to light.
It is important to tell your doctor if you experience any skin problems while taking this medicine. Your doctor may recommend topical creams or ointments to soothe the skin or antibiotics to treat any infections that may develop. Infusion reactions can happen as a side effect of this drug, which are allergic reactions that can occur during or shortly after the infusion of the medication. To minimize the risk of infusion reactions, your doctor will monitor you closely during and after the infusion and may give you medications such as antihistamines and corticosteroids to prevent or treat any allergic reactions that may occur. Vectibix 100mg injection is not recommended during pregnancy as it causes harm to the unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and for 3 months after the last dose of the drug.
| Business Type | Exporter, Supplier |
| Packaging Size | 10 Tablets |
| Packaging Type | Box |
| Form | Tablet |
| Brand Name | Veenat |
| Dose/Strength | 400 Mg |
| Composition | Imatinib |
Veenat 400mg tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used in treating adults and children with chronic myeloid leukemia (CML- it is a form of leukemia in which certain abnormal white blood cells start growing out of control). It is also indicated to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). It is also used to treat certain types of gastrointestinal stromal tumors (GIST, a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body).
Veenat 400mg tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD); these are a group of blood diseases in which some blood cells start growing out of control. They also treat hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL); these are blood diseases in which some blood cells (eosinophils) start growing out of control. This medicine is also intended to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works to inhibit the growth of these abnormal blood cells.
Do not take Veenat 400mg tablet if you are allergic to imatinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have kidney, heart, or liver problems, if you have thyroid problems, or if your thyroid gland has been removed. Notify your doctor if you ever had or have a hepatitis B infection because this medicine could cause the hepatitis B to become active again. Report any symptoms of bruising, bleeding, fever, fatigue, and confusion when taking this medicine. This medicine may cause fertility problems.
| Business Type | Exporter, Supplier, Trader |
| Packaging | Box |
| Active Ingredient | Bevacizumab |
| Brand | Versav |
| Strength | 400 Mg/16 Ml |
| Pharmaceutical Form | Solution For Infusion |
| Volume | 16 Ml |
| Manufacturer | DR REDDY'S |
Versavo 400mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Versavo 400mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.
Versavo 400mg Injection is often administered as a combination with other chemotherapy agents.
Constipation, appetite loss, runny nose, fever, skin problems, and weight loss are common side effects of Versavo 400mg Injection. Before starting treatment with this medicine, let your doctor know if you have high blood pressure, high blood sugar, stomach disorders, or heart problems. This medicine should not be taken for 28 days before and after surgery as it is associated with poor wound healing and high bleeding complications. It is advised to report to your doctor if you have any dental issues that require surgery before taking this medicine. In case you develop any visual changes or confusion, report to your doctor to prevent complications.
| Business Type | Exporter, Supplier |
| Form | Tablet |
| Composition | Abiraterone Acetate |
| Manufactured By | Cipla Ltd |
| Brand | Xbira 500mg |
| Strength | 500 Mg |
| Packaging | Bottle |
| Usage/Application | Prostate Cancer |
| Tablets Per Pack | 60 Tablets |
Xbira 500mg Tablet contains the active constituent abiraterone acetate. It is used in adult men to treat prostate cancer, which has spread to other parts of the body. It is usually given with steroid medication to lower the chances of side effects. When Xbira 500mg Tablet is prescribed for an early stage of this disorder, it is used with testosterone lowering treatment. This medicine is not for use in women or children. Effective contraception must be taken throughout the treatment. This medicine contains lactose and sodium, inform your physician if you have lactose intolerance or on a salt control diet.
Inform to the physician if the patients have liver problems, high blood pressure, heart disorders, low blood potassium, diabetes, allergic conditions, or other diseases. Make sure to inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start the treatment with this medication. The most common side effects of this medication are fluid in feet or legs, high blood pressure, and diarrhea. A decrease in red blood cells and reduced sex drive may also occur with the intake of Xbira 500mg Tablet. This medicine should not be taken with Ra-223, which is used to treat prostate cancer.